Table 1 Demographic characteristics of patients
Overall (N=137) | Propensity score-matched pairs (n=88) | |||||
|---|---|---|---|---|---|---|
Lap (n=85) | SILS (n=52) | P value | Lap (n=44) | SILS (n=44) | P value | |
Age, years, median (IQR) | 71 (63-78) | 69 (63-74) | 0.444 | 67 (57-75) | 69 (60-74) | 0.551 |
Sex, male, n (%) | 57 (67.1) | 27 (51.9) | 0.104 | 19 (43.2) | 19 (43.2) | 1 |
BMI, kg/m2, median (IQR) | 23.0 (20.9-24.9) | 23.1 (20.9-25.1) | 0.982 | 22.8 (20.0-25.5) | 23.3 (20.9-25.0) | 0.679 |
ECOG-PS, 0 or 1, n (%) | 84 (98.8) | 50 (96.2) | 0.557 | 43 (97.7) | 43 (97.7) | 1 |
ASA score, 1 or 2, n (%) | 72 (84.7) | 42 (80.8) | 0.639 | 37 (84.1) | 36 (81.8) | 1 |
Previous abdominal surgery, n (%) | 17 (20) | 17 (32.7) | 0.107 | 12 (27.3) | 11 (25) | 1 |
Clinical TNM stage, n (%) | 0.456 | 0.906 | ||||
I | 33 (38.8) | 15 (28.9) | 17 (38.6) | 15 (34.1) | ||
II | 26 (30.6) | 17 (32.7) | 14 (31.8) | 15 (34.1) | ||
III | 26 (30.6) | 20 (38.5) | 13 (29.6) | 14 (31.8) | ||
*Comorbidities, n (%) | ||||||
Cardiac | 11 (12.9) | 8 (15.4) | 0.800 | 2 (4.6) | 6 (13.6) | 0.266 |
Pulmonary | 13 (15.3) | 7 (13.5) | 0.809 | 6 (13.6) | 6 (13.6) | 1 |
Diabetes | 19 (22.4) | 7 (13.5) | 0.263 | 8 (18.2) | 5 (11.4) | 0.549 |
Cerebrovascular | 8 (9.4) | 9 (17.3) | 0.191 | 4 (9.1) | 7 (15.9) | 0.521 |
Anticoagulant therapy | 12 (14.1) | 9 (17.3) | 0.632 | 3 (6.8) | 8 (18.2) | 0.196 |